Italy· 049685035
EVRENZO*12x1 cpr rivestite 70 mg dose unitaria
A roxadustat product containing roxadustat, registered in Italy by ASTELLAS PHARMA EUROPE B.V., on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Roxadustat is registered in 13 of 19 countries.
Countries holding a registration under ATC B03XA05 (roxadustat), each read from that country’s own register.
- This record: Italy
- 8 of them publish a price we can compare per daily dose
Roxadustat · ATC B03XA05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of roxadustat costs, country by country.
Normalised to the WHO defined daily dose (43 mg), the median price runs from $23.73 in Italy to $77.81 in France — a ×3.3 gap.
- Italy: $23.73 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Roxadustat · price per daily dose (43 mg)
USD · FX 28 Sept 2026
- FR France$77.81
- IT Italy$23.73
The record
At a glance
- Active substance
- Roxadustat
- Manufacturer
- ASTELLAS PHARMA EUROPE B.V.
- Country
- Italy (IT)
- ATC code
- B03XA05
- ATC class
- Roxadustat
- Defined daily dose
- 43 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic049685035EVRENZO*12x1 cpr rivestite 70 mg dose unitariaEUR 407.12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Roxadustat in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEvrenzoAstellas Pharma Europe B.V.
- CzechiaEVRENZOAstellas Pharma Europe B.V., Leiden
- FranceEVRENZO 100 mg, comprimé pelliculéASTELLAS PHARMA EUROPE (PAYS-BAS)
- United KingdomEvrenzo 100mg tabletsAstellas Pharma Ltd
- IrelandEvrenzo 100 mg Film-coated tabletAstellas Pharma Europe B.V.
- IcelandEvrenzoAstellas Pharma Europe B.V.
- SwedenEvrenzo 100 mg Filmdragerad tablettAstellas Pharma Europe BV
- SpainEVRENZO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstellas Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evrenzo
- Liechtenstein · Evrenzo
- Norway · Evrenzo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf1bff7d-c26e-4f89-9d0a-8a281157c5ca GET /v1/drugs/bf1bff7d-c26e-4f89-9d0a-8a281157c5ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 407.12,
"source": "aifa",
"currency": "EUR",
"strength": "ROXADUSTAT 70MG 12 UNITA' USO ORALE",
"substance": "Roxadustat",
"equivalence_group": "MKW",
"transparency_flag": null
}See everything about roxadustat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.